NCT03149393

Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 384 (estimated)
• Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, double blind, double dummy, multicenter, parallel controlled clinical trial, the investigators objective is to evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of functional dyspepsia.

Detailed description

This study is a randomized, double blind, double dummy, multicenter, parallel controlled clinical trial, the investigators objective is to evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of functional dyspepsia. The experiment will be carried out in 8 sub centers at the same time, and the investigators estimated that there will be 384 cases of income, including the experimental group and the control group (n = 192), and the investigators choose mosapride citrate tablets for drug control.

Conditions

• Functional Dyspepsia
• Traditional Chinese Medicine

Interventions

Type	Name	Description
DRUG	Qizhi Weitong Granules	Patients in this group will take Qizhi Weitong Granules 2.5g,3 times/day,30 minutes before dinner for 8 weeks.
DRUG	Mosapride Citrate Tablets	Patients in this group will take mosapride citrate tablets 5mg,3 times/day,30 minutes before dinner for 8 weeks.

Timeline

• Start date: 2017-02-01
• Primary completion: 2020-12-31
• Completion: 2020-12-31
• First posted: 2017-05-11
• Last updated: 2020-02-28

Locations

1 site across 1 country: China